Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Joshua R. Disbrow | Chief Executive Officer | 2022-12-19 | 112,371 | $0.22 | $25.06kBuy |
Greg Pyszczymuka | Chief Commercial Officer | 2022-12-19 | 100,000 | $0.25 | $24.50kBuy |
Joshua R. Disbrow | Chief Executive Officer | 2022-11-18 | 222,000 | $0.24 | $52.61kBuy |
Joshua R. Disbrow | Chief Executive Officer | 2022-11-18 | 222,000 | $0.24 | $52.61kBuy |
Mark K. Oki | Chief Financial Officer | 2022-11-18 | 90,000 | $0.23 | $20.70kBuy |
Mark K. Oki | Chief Financial Officer | 2022-11-18 | 90,000 | $0.23 | $20.70kBuy |
Mark K. Oki | Chief Financial Officer | 2022-11-18 | 90,000 | $0.23 | $20.70kBuy |
Joshua R. Disbrow | Chief Executive Officer | 2022-11-18 | 222,000 | $0.24 | $52.61kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Armistice Capital LLC | 310.05% | 11,078,956 | $23.27M | Insider |
Cerecor Inc | 271.83% | 9,713,068 | $20.40M | Insider |
James B. Wiegand | 65.50% | 2,340,659 | $4.92M | Insider |
Renaissance Technologies LLC | 59.91% | 2,140,782 | $4.50M | Institution |
Alyeska Investment Group LP | 41.98% | 1,500,000 | $3.15M | Institution |
Ampio Pharmaceuticals Inc | 34.32% | 1,226,407 | $2.58M | Insider |
Millennium Management LLC | 33.30% | 1,189,958 | $2.50M | Institution |
Christopher Brooke | 32.66% | 1,167,147 | $2.45M | Insider |
Joshua R. Disbrow | 32.24% | 1,151,877 | $2.42M | Insider |
Carl Dockery | 28.99% | 1,035,790 | $2.18M | Insider |